What is Medical Marijuana I?
, an investment holding company, operates in the cannabinoid-based nutraceutical industry.
MJNA · Verdict
Moderate reward · elevated risk
MJNA stands out on volatility and valuation, but watch the balance sheet signal.
Based on 88% data coverage
MJNA · Verdict
Top decile vs peers
Above average
Current ratio 0.68
Rev -24.1% CAGR · earnings -48.8%
7% free-cash-flow margin
Model-based scoring. For information only — not financial advice.
, an investment holding company, operates in the cannabinoid-based nutraceutical industry. It engages in creating international CBD pipeline; produces legal cannabis products; develops cannabis drug and medication; supports services for cannabis industry; and develops market for medical cannabis. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.99M.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.